Kura Oncology, Inc.
11119 N. Torrey Pines Road
Suite 125
La Jolla, CA 92037
(858) 500-8800
July 17, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey P. Riedler
Re: | Kura Oncology, Inc. |
Registration Statement on Form S-1
Filed: April 17, 2015
File No. 333-203503
Ladies and Gentlemen:
Kura Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective at 4:00 p.m. Eastern Time on Tuesday, July 21, 2015, or as soon thereafter as is practicable. The Registrant also hereby requests a copy of the written order verifying the effective date.
In connection with this request, the Registrant hereby acknowledges that:
• | should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; |
• | the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and |
• | the Registrant may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Sincerely,
KURA ONCOLOGY, INC.
By: | /s/ Heidi Henson | |
Heidi Henson | ||
Chief Financial Officer | ||
cc: | Charles J. Bair, Cooley LLP | |
James Pennington, Cooley LLP |